Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034

The personalized medicine market is experiencing strong growth driven by advances in genomics, biomarker-based diagnostics, and targeted therapies. The increasing prevalence of chronic diseases and cancer is accelerating demand for tailored treatment approaches that improve efficacy and reduce adverse effects. Technological innovations such as next-generation sequencing and AI-powered data analytics are further enabling precise patient stratification.

New York, USA, May 11, 2026 (GLOBE NEWSWIRE) — Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

DelveInsight’s Personalized Medicine Market Insights report provides the current and forecast market analysis, individual leading personalized medicine companies’ market shares, challenges, personalized medicine market drivers, barriers, trends, and key personalized medicine companies in the market.

Personalized Medicine Market Summary

2025 Personalized Medicine Market Size: USD 524 Billion
2034 Projected Personalized Medicine Market Size: USD 1 Trillion
Personalized Medicine Market Growth Rate (2026-2034): ~9%
Largest Personalized Medicine Market: North America
Largest Product Type Segment: Personalized Nutrition & Wellness Category
Key Companies in the Personalized Medicine Market: Novartis AG, bluebird bio, Spark Therapeutics, BioMarin Pharmaceutical, CSL Behring, Vertex Pharmaceuticals, Pfizer Inc., Amgen Inc., Dendreon Pharmaceuticals, Kite Pharma, Janssen Biotech, Bristol-Myers Squibb, Ferring Pharmaceuticals, Krystal Biotech, Myriad Genetics, Illumina, Inc., Thermo Fisher Scientific, Roche Diagnostics, 23andMe, Helix, Tempus, Foundation Medicine, Guardant Health, Nutrigenomix, Vitl, GenoPalate, DayTwo, Panaceutics, AHARA, Ayble Health, Season Health, ModifyHealth, LifeNome, Viome, Zoe, Amway (Nutrilite), Herbalife Nutrition, BASF, Nestlé Health Science, Vita Bella Health, Practo, mfine, Lybrate, Teladoc Health, Amwell, Doctor On Demand, and others

To read more about the latest highlights related to the personalized medicine market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/personalized-medicine-market

Key Factors Contributing to the Rise in Growth of the Personalized Medicine Market

Advancements in Genomics and Molecular Biology: Rapid progress in genomic sequencing technologies and biomarker discovery has made it possible to understand individual genetic profiles at a much deeper level. The declining cost of genome sequencing and expansion of genomic databases have significantly improved accessibility to precision-based treatments.
Rising Demand for Targeted Therapies: Healthcare is shifting from a “one-size-fits-all” approach to targeted and patient-specific treatments, particularly in oncology, rare diseases, and chronic conditions. Personalized therapies improve treatment efficacy and reduce adverse effects, driving adoption across healthcare systems.
Increasing Prevalence of Chronic and Complex Diseases: The growing global burden of diseases such as cancer, cardiovascular disorders, and diabetes is accelerating the need for individualized treatment strategies. Personalized medicine enables early diagnosis and optimized therapy selection, improving clinical outcomes.
Integration of Artificial Intelligence and Big Data: The use of AI, machine learning, and advanced analytics is transforming personalized medicine by enabling faster and more accurate analysis of complex biological data. This supports biomarker identification, predictive modeling, and clinical decision-making.
Growth in Precision Diagnostics and Companion Diagnostics: Advancements in molecular diagnostics, liquid biopsies, and companion diagnostics are enhancing the ability to match patients with the most effective therapies. These tools enable early detection and precise disease characterization, boosting market growth.
Increasing Patient Awareness and Preventive Healthcare Trends: Consumers are becoming more aware of their genetic predispositions and are actively seeking personalized health insights, including genetic testing, personalized nutrition, and wellness solutions. This shift toward preventive care is expanding the market beyond traditional therapeutics.
Strong Investment and Strategic Collaborations: Rising investments from pharmaceutical, biotech, and technology companies, along with strategic partnerships between drug developers and diagnostic firms, are accelerating innovation and commercialization of personalized solutions.
Expansion of Digital Health and Telemedicine: Digital health platforms, electronic health records, and telemedicine are enabling data-driven, patient-centric care delivery, making personalized medicine more scalable and accessible across regions.
Government Support and Regulatory Advancements: Governments and regulatory bodies are increasingly supporting precision medicine initiatives through funding, national genomics programs, and frameworks for biomarker validation, which is fostering market growth.
Growth of Biologics, Gene Therapy, and Pharmacogenomics: Advances in biologics, gene therapies, and pharmacogenomics are enabling highly individualized treatment approaches, particularly in oncology and rare diseases, further fueling market expansion.

Get a sneak peek at the personalized medicine market dynamics @ Personalized Medicine Market Trends

Regional Personalized Medicine Market Insights

North America

North America held the largest share, approximately 41%, of the personalized medicine market in 2025 among all regions.
This leadership is driven by the region’s well-established healthcare infrastructure, a strong concentration of major biotechnology and pharmaceutical players, and widespread adoption of advanced technologies such as next-generation sequencing and artificial intelligence.
Furthermore, robust government support, favorable regulatory policies, and rising demand for precision diagnostics and targeted therapies continue to reinforce North America’s dominant position in the market.

Europe

The personalized medicine market in Europe is experiencing robust and consistent expansion, largely fueled by significant progress in genomic technologies, rising uptake of targeted treatments, the growing role of pharmacogenomics, and supportive regulatory frameworks led by the European Medicines Agency (EMA).
The increasing utilization of next-generation sequencing (NGS), liquid biopsies, and sophisticated molecular diagnostic tools is enhancing the early identification of genetic alterations and enabling more accurate treatment decisions, especially in oncology and rare disorders.
Simultaneously, the adoption of targeted therapies, including monoclonal antibodies, gene therapies, and CAR-T cell treatments, is transforming clinical approaches by focusing on specific disease biomarkers, which enhances patient outcomes while minimizing side effects.
In addition, pharmacogenomics is gaining momentum across European healthcare systems, allowing clinicians to customize drug choices and dosages based on individual genetic makeup, thereby improving both the safety and efficacy of treatments.

Asia-Pacific

The Asia-Pacific region is becoming a key engine of growth in the personalized medicine market, driven by rapid progress in genomic technologies, robust government backing for precision healthcare, a growing prevalence of chronic diseases, and wider adoption of targeted and pharmacogenomics-based therapies.
Nations such as China, Japan, South Korea, and India are making substantial investments in next-generation sequencing (NGS), AI-enabled diagnostics, and expansive genomic research initiatives, which are enhancing early disease detection and supporting more tailored treatment approaches.
Additionally, the region is experiencing significant growth in its biotechnology sector and clinical trial landscape, establishing APAC as a prominent center for innovative drug development and precision medicine, with a steadily increasing share in the global biopharmaceutical innovation pipeline.

To know more about why North America is leading the market growth in the personalized medicine market, get a snapshot of the Personalized Medicine Market Share

Recent Developmental Activities in the Personalized Medicine Market

In April 2026, Roche initiated a new late-stage study for its gene therapy Elevidys following EMA feedback, reflecting ongoing regulatory engagement to enable future approval in Duchenne muscular dystrophy.
In March 2026, ZOE Limited announced the launch of ZOE 2.0, the latest step toward revolutionizing gut health and improving the health of millions. The new ZOE app is a personalised nutrition science powerhouse based on the world’s largest nutrition and microbiome science study.
In February 2026, Japan continued strengthening its precision medicine ecosystem, with regulatory approvals for advanced medical technologies such as the Clarity II laser platform approved in China and Japan.

What is Personalized Medicine?

Personalized medicine, also known as precision medicine, is an approach to healthcare that tailors medical treatment and preventive strategies to an individual’s unique biological profile, lifestyle, and environment. It leverages advanced technologies such as genomics, biomarker analysis, and data analytics to understand how a person’s genetic makeup influences disease risk and response to therapies. Unlike the traditional “one-size-fits-all” model, personalized medicine enables clinicians to select the most effective treatments with fewer side effects, improving patient outcomes. This approach is particularly transformative in areas like oncology, rare diseases, and chronic conditions, where targeted therapies can significantly enhance treatment efficacy and quality of life.

Personalized Medicine Market Report Metrics	Details
Coverage	Global
Study Period	2023–2034
Personalized Medicine Market CAGR	~9%
Personalized Medicine Market Size by 2034	USD 1 Trillion
Key Personalized Medicine Companies	Novartis AG, bluebird bio, Spark Therapeutics, BioMarin Pharmaceutical, CSL Behring, Vertex Pharmaceuticals, Pfizer Inc., Amgen Inc., Dendreon Pharmaceuticals, Kite Pharma, Janssen Biotech, Bristol-Myers Squibb, Ferring Pharmaceuticals, Krystal Biotech, Myriad Genetics, Illumina, Inc., Thermo Fisher Scientific, Roche Diagnostics, 23andMe, Helix, Tempus, Foundation Medicine, Guardant Health, Nutrigenomix, Vitl, GenoPalate, DayTwo, Panaceutics, AHARA, Ayble Health, Season Health, ModifyHealth, LifeNome, Viome, Zoe, Amway (Nutrilite), Herbalife Nutrition, BASF, Nestlé Health Science, Vita Bella Health, Practo, mfine, Lybrate, Teladoc Health, Amwell, Doctor On Demand, and others

Personalized Medicine Market Assessment

Personalized Medicine Market Segmentation
- Personalized Medicine Market Segmentation By Product Type: Personalized Therapeutics, Personalized Diagnostics, Personalized Nutrition & Wellness, and Personalized Digital Health & Telemedicine
- Personalized Medicine Market Segmentation By Application: Oncology, Cardiovascular Diseases, Neurology, Infectious Diseases, and Others
- Personalized Medicine Market Segmentation By End User: Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Others
- Personalized Medicine Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the personalized medicine market are set to emerge as the trendsetter explore @ Personalized Medicine Market Analysis

Table of Contents

1	Personalized Medicine Market Report Introduction
2	Personalized Medicine Market Executive Summary
3	Personalized Medicine Market Key Factors Analysis
4	Impact Analysis
5	Regulatory Analysis
6	Personalized Medicine Market Porter’s Five Forces Analysis
7	Personalized Medicine Market Assessment
8	Competitive Landscape
9	Startup Funding & Investment Trends
10	Personalized Medicine Market Company and Product Profiles
11	KOL Views
12	Project Approach
13	About DelveInsight
14	Disclaimer & Contact Us

Interested in knowing the personalized medicine market share by 2034? Click to get a snapshot of the Personalized Medicine Market Size

Related Reports

Artificial Intelligence in Precision Medicine Market

Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and others.

Next-Generation Sequencing Market

Next-Generation Sequencing Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key NGS companies, including Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Molecular Diagnostics, Inc., and others.

Telehealth Market

Telehealth Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key telehealth companies, including Teladoc Health, Inc., Siemens, Cisco Systems, Inc., Koninklijke Philips N.V., IBM Corporation, Medtronic, Cerner Corporation, American Well, AMD Global Telemedicine, Joerns Healthcare., GlobalMed, OncoHealth, Allscripts Healthcare, LLC, Derma2go, SOCTelemed, Inc., Honeywell International Inc., Plantronics, Inc., Carium., Emmaus Life Sciences, Inc., Practo, and others.

Telemedicine Market

Telemedicine Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key telemedicine companies, including Teladoc Health, Inc., MEDICI, American Well, Doximity, Inc., Practo, DocOnline, MeMD®, iCliniq, HealthTap, Inc., WELL Health Technologies Corp., Vesta Teleradiology, USARAD.CO, Samsung Health U.S, Rudolf Riester GmbH, SHL Telemedicine, Array Behavioral Care, SOC Telemed, Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd., First Derm, DirectDerm, and others.

Digital Health Market

Digital Health Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key digital health companies, including Siemens Healthcare Private Limited, Cisco Systems, Inc., Oracle Cerner, Altera Digital Health Inc., Telefonica, Epic, AT&T, AmerisourceBergen, Candela Corporation., GE Healthcare, Samsung Health, MCKESSON CORPORATION, AliveCor, Inc., Acurable, Amwell, OMRON Healthcare, Inc., Apple Inc., SoftServe, AirStrip Technologies, Inc, Epic Systems Corporation, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

CONTACT: Contact Us

Shruti Thakur 

[email protected] 

+14699457679

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Mango Bunch takes no editorial responsibility for the same.